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Turning a new page in virology
The easiest way to order: w w w.karger.com/int At the beginning of the 21st century, a microorganism which was visible under the microscope, could be Gram-stained and had been considered a bacterium for several years was identified as Mimivirus, the largest virus known at the time. This opened up the world of giant viruses which are today considered to represent a fourth domain of microbes. In this special issue of Intervirology, recent findings on two new families of giant viruses, Marseilleviridae and Mimiviridae, are presented. The data confirm that both groups of viruses may be found in the environment (soil, water, insects) and in humans (blood, stool) . New techniques to culture, purify and isolate these viruses are also reported. These new findings show that the world of giant viruses is expanding, and challenge the traditional classification of microbes into three domains (bacteria, archaea and eukaryotes) based on size and ribosomal genes. A new classification of microbes into four branchesgiant viruses (Megavirales), bacteria, archaea and eukaryotes -is postulated which reflects more realistically our current knowledge of the microbial world. Anyone interested in this revolution in virology should read this publication which may contribute to the discovery of further giant viruses that are as yet unknown. • Codon Usage, Amino Acid Usage, Transfer RNA and Amino-Acyl-tRNA Synthetases in Mimiviruses:
Contents
Colson, P.; Fournous, G.; Diene, S.M.; Raoult, D.
• • Describing the Silent Human Virome with an Emphasis on Giant Viruses: Popgeorgiev, N.; Temmam, S.; Raoult, D.; Desnues, C.
• Real-Time PCR Systems Targeting Giant Viruses of Amoebae and Their Virophages: Ngounga, T.;
www.karger.com/int
Should you experience problems with your submission, please contact: Names, postal and e-mail addresses of three experts in the appropriate area of research should accompany each manuscript. Selected scientist(s) will be invited to act as referee(s). Referees suggested should not be from the same institution as the author and should have expert knowledge of the subject. Please suggest not more than one from your own country.
Conditions
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An article based on trials performed on animals requires a statement that approval from an independent ethics committee has been obtained, signed by all authors.
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Issues in Infectious Diseases
Infections are a constant threat to human health. Over the last two decades a number of new infective agents such as HIV and prions have been identifi ed, and several infectious diseases previously considered under control have suddenly reemerged. The problem of infection is aggravated by the resistance of many microorganisms to currently available antiinfectives and by the growing number of immuno-compromised people worldwide. The steadily rising incidence of nosocomial infections is a further cause for concern. This series presents original data and reviews the latest clinical information on infectious diseases of bacterial, viral, fungal and parasitic origin. Covering epidemiology, pathogenesis, prevention and treatment, it also considers the latest diagnostic techniques, evaluates new antimicrobial drugs and reports recent advances in vaccine development. As infections involve almost all branches of medicine, books published in this series represent a valuable source of information for a wide spectrum of clinicians and health care professionals.
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Review Articles
• Liver Failure due to Acute Viral Hepatitis (A-E): Manka, P.; Verheyen, J.; Gerken, G.; Canbay, A.
• Management of HBV and HBV/HDV-Associated Liver Cirrhosis:
Höner zu Siederdissen, C.; Cornberg, M.
• Management of HCV-Associated Liver Cirrhosis: Schneider, M.D.;
Sarrazin, C.
• Pre-and Post-Transplant Antiviral Therapy (HBV, HCV):
Welker, M.-W.; Zeuzem, S.
• • 
G O T T F R I E D S C H A T Z A M ATT E R O F W O N D E R WHAT BIOLOGY RE VE AL S ABOUT US , OUR WORLD, AND OUR DRE A MS A M A T T E R O F W O N D E R WHAT BIOLOGY REVEAL S ABOUT US, OUR WORLD, AND OUR DREAMS G O T T F R I E D S C H A T Z
A collection of extraordinary essays on key issues in the natural sciences
Where do we come from? Is our destiny determined by the genes we inherit? Do we all see the same blue color when we look at the sky? In this book Gottfried (Jeff) Schatz, the worldrenowned biochemist, gives lucid -albeit often surprising -answers to universal questions and takes the reader on a fascinating journey of discovery across the boundaries of scientifi c disciplines. With passion and a keen sense of wonder he draws on philosophy, cultural history and art to formulate his refl ections on the mystery of life. The key to understanding life is to be found in its chemistry, and he proves that this is no dry endeavor and certainly not devoid of beauty. The result is a collection of eloquently and poetically written essays dealing with key issues in the natural sciences. It will appeal not only to scientists, but also to all inquisitive minds, regardless of educational and professional background. More information and sample essays at
www.karger.com/schatz
Orders can be placed at agencies, bookstores or directly with the publisher. Also available through Amazon.com.
'
A collection of extraordinary essays, reminiscent in many ways -scope, erudition, clarity, occasional whimsicality and sassiness -of Stephen Jay Gould's essays for Natural History
Herbert Deinert (Cornell University, Ithaca, N.Y.)
A remarkable fusion of science and humanism
Eugene P. Kennedy (Harvard University, Boston, Mass.)
